| Governmental influences on drug development: striking a better balance. | |
| | |
MedLine Citation:
|
PMID: 17491596 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There is currently considerable debate in many countries over the effects of public policy - in particular, governmental regulation - on the development of innovative pharmaceuticals. Regulators must balance patients' access to therapies with ensuring the safety of drugs. The consequences of poor decisions can be dire: if access is promoted at the expense of safety, a dangerous product can cause incalculable harm; conversely, if safety is over-emphasized at the expense of access, patients can suffer from the absence of life-saving and life-enhancing medications. Using the United States as an example, we discuss the influence of governmental bodies such as the US Food and Drug Administration (FDA), as well as recent legislative initiatives, on pharmaceutical innovation. We argue for a balanced approach to governmental interventions. |
| | |
Authors:
|
Henry I Miller; David R Henderson |
Related Documents
:
|
17361066 - Assessment of feed additives and contaminants: an essential component of food safety. 16483706 - The impact of food regulation on the food supply chain. 21067676 - Risk ranking: investigating expert and public differences in evaluating food safety haz... 15228986 - Human rights and the governance of food quality and safety in china. 5540306 - Microbial degradation of organic matter in the deep sea. 17361066 - Assessment of feed additives and contaminants: an essential component of food safety. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Nature reviews. Drug discovery Volume: 6 ISSN: 1474-1776 ISO Abbreviation: Nat Rev Drug Discov Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-06-29 Completed Date: 2007-08-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101124171 Medline TA: Nat Rev Drug Discov Country: England |
Other Details:
|
Languages: eng Pagination: 532-9 Citation Subset: IM |
Affiliation:
|
Hoover Institution, Stanford University, Stanford, California 94305, USA. miller@hoover.stanford.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Costs
/
legislation & jurisprudence Drug Design* Drug Industry Drug and Narcotic Control* Government Humans Public Health Safety United States United States Food and Drug Administration |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Atomic resolution insight into host cell recognition by Toxoplasma gondii.
Next Document: Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to pr...